(Q35548424)

English

Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis

scientific article published on February 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 August 2017

Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis (English)

1 reference

Europe PubMed Central

8 August 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Haagsma CJ

1

1 reference

Europe PubMed Central

8 August 2017

Blom HJ

2

1 reference

Europe PubMed Central

8 August 2017

van Riel PL

3

1 reference

Europe PubMed Central

8 August 2017

van't Hof MA

4

1 reference

Europe PubMed Central

8 August 2017

Giesendorf BA

5

1 reference

Europe PubMed Central

8 August 2017

van Oppenraaij-Emmerzaal D

6

1 reference

Europe PubMed Central

8 August 2017

van de Putte LB

7

1 reference

Europe PubMed Central

8 August 2017

language of work or name

0 references

publication date

1 February 1999

1 reference

Europe PubMed Central

8 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

8 August 2017

58

1 reference

Europe PubMed Central

8 August 2017

2

1 reference

Europe PubMed Central

8 August 2017

79-84

1 reference

Europe PubMed Central

8 August 2017

Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752831

12 July 2018

Molecular therapeutics. Methotrexate and its mechanism of action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752831

12 July 2018

Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752831

12 July 2018

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752831

12 July 2018

Methotrexate in rheumatoid arthritis. An update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752831

12 July 2018

Polyglutamation of methotrexate. Is methotrexate a prodrug?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752831

12 July 2018

Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752831

12 July 2018

The in vitro effects of methotrexate on peripheral blood mononuclear cells. Modulation by methyl donors and spermidine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752831

12 July 2018

Homocysteine levels in patients with rheumatoid arthritis treated with low-dose methotrexate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752831

12 July 2018

Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752831

12 July 2018

Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752831

12 July 2018

Inhibition of Folate Enzymes by Sulfasalazine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752831

12 July 2018

Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752831

26 September 2018

Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrexate treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752831

26 September 2018

Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10343521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does sulphasalazine cause folate deficiency in rheumatoid arthritis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10343521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10343521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent use of folinic acid and methotrexate in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10343521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10343521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multivitamin supplementation in oral contraceptive users

1 reference

https://pubmed.ncbi.nlm.nih.gov/10343521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10343521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 week randomized placebo controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10343521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10343521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three different methods for the determination of total homocysteine in plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10343521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida

1 reference

https://pubmed.ncbi.nlm.nih.gov/10343521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is the common 677C-->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10343521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10343521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.58.2.79

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35548424&oldid=1525333234"